European Companies Search Engine
Managing Director: Bernhard Frerich · Change of headquarters: NovaTissue GmbH · Address · Capital: €145,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb26 Mar 2010 German Trade Register Announcements, Germany (23/03/2010)
Overview
Text
NovaTissue GmbH,
Unnamed street ??, 18059 Rostock, Germany
. GmbH. partnership agreement of July 21, 2005, amended several times. The shareholders' meeting of February 4, 2010 decided to amend the partnership agreement in Section 1 (2) and with it the transfer of its registered office from Leipzig (previously Leipzig HRB 21844) to Rostock. Business address:
Unnamed street ??, 18059 Rostock, Germany
. Subject: Research, development, production and marketing of products and services for tissue replacement by means of tissue engineering. Tissue engineering of adipose tissue is realized using autologous progenitor cells. In particular, products and services for wrinkle injection, the plastic-aesthetic construction of facial parts and the treatment of scars and soft tissue defects are provided. Share capital: EUR 145,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Appointed as Managing Director: Prof. Dr. Dr. Frerich, Bernhard, Rostock, *??.??.????, authorized to represent one another; with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: NovaTissue GmbH, Rostock, Germany.